Bio-Rad Laboratories (BIO.B) News Today $312.05 0.00 (0.00%) As of 02/20/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Bio-Rad Laboratories Full Year 2024 Earnings: EPS Misses ExpectationsFebruary 15, 2025 | finance.yahoo.comBio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2024 Earnings Call TranscriptFebruary 15, 2025 | msn.comBio-Rad Laboratories (NYSE:BIO.B) Releases Earnings ResultsBio-Rad Laboratories (NYSE:BIO.B - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $2.90 EPS for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.74% and a negative net margin of 30.18%.February 14, 2025 | marketbeat.comBio-Rad price target lowered to $447 from $477 at RBC CapitalFebruary 14, 2025 | markets.businessinsider.comBio-Rad Laboratories Shares Fall on 4Q Sales Miss, Cost-Cutting PlansFebruary 14, 2025 | marketwatch.comBay Area biotech giant Bio-Rad to lay off hundreds after $1.8 billion lossFebruary 14, 2025 | msn.comBio-Rad sees FY25 currency neutral revenue growth 1.5%-3.5%February 14, 2025 | markets.businessinsider.comBio-Rad targets 1.5%-3.5% revenue growth in 2025 amid operational improvements and new acquisitionsFebruary 14, 2025 | msn.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - What's Next?Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - What's Next?February 12, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - Here's WhyBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - What's Next?February 6, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Hits New 52-Week High - Time to Buy?Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 12-Month High - Time to Buy?January 30, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume Increase - Here's WhyBio-Rad Laboratories (NYSE:BIO.B) Sees Unusually-High Trading Volume - Here's WhyJanuary 29, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (BIO): Is This Healthcare Stock A Good Buy?January 28, 2025 | msn.comBIO Bio-Rad Laboratories, Inc.January 28, 2025 | seekingalpha.comS&P 500 Futures Steady in Premarket Trading; Stevanato Group, Bio-Rad Labs A LeadJanuary 28, 2025 | marketwatch.comBio-Rad Laboratories (NYSE:BIO.B) Sets New 52-Week High - What's Next?Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 12-Month High - Time to Buy?January 24, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - Here's What HappenedBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - What's Next?January 21, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up - Should You Buy?Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up - Time to Buy?January 8, 2025 | marketbeat.comBio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare ConferenceJanuary 2, 2025 | businesswire.comBio-Rad Laboratories (NYSE:BIO.B) Trading Up 2.3% - Should You Buy?Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 2.3% - Should You Buy?December 17, 2024 | marketbeat.comBio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare ConferenceNovember 21, 2024 | finance.yahoo.comBio-Rad Laboratories (NYSE:BIO.B) Reaches New 52-Week High - Here's What HappenedBio-Rad Laboratories (NYSE:BIO.B) Reaches New 52-Week High - Time to Buy?November 8, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their EstimatesNovember 3, 2024 | uk.finance.yahoo.comWells Fargo Remains a Hold on Bio-Rad Laboratories (BIO)November 2, 2024 | markets.businessinsider.comBio-Rad Laboratories Reports Q3 2024 Earnings GrowthNovember 1, 2024 | markets.businessinsider.comPlatforma.bio by MiLaboratories is making waves in drug discoveryOctober 18, 2024 | venturebeat.comPCR Technologies Market to Hit USD 21.89 Billion by 2030 with 7.7% CAGR | MarketsandMarketsOctober 12, 2024 | finanznachrichten.deBio-Rad Laboratories Stock: Is BIO Underperforming the Healthcare Sector?September 30, 2024 | msn.comCS Genetics Appoints Bill Colston, PhD, as Chief Executive OfficerSeptember 25, 2024 | finance.yahoo.comBio-Rad Laboratories (NYSE:BIO.B) Trading Down 0%Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 0%September 12, 2024 | marketbeat.comBio-Rad Appoints Jon DiVincenzo President, Chief Operating OfficerAugust 20, 2024 | finance.yahoo.comBio-Rad Laboratories, Inc. (NYSE:BIO) Q2 2024 Earnings Call TranscriptAugust 3, 2024 | msn.comBio-Rad Laboratories (NYSE:BIO.B) Issues Quarterly Earnings ResultsBio-Rad Laboratories (NYSE:BIO.B - Get Free Report) issued its earnings results on Thursday. The company reported $3.11 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.59% and a negative net margin of 12.37%. The business had revenue of $638.48 million during the quarter.August 2, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up to $294.23Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up to $294.23August 2, 2024 | marketbeat.comThe Future is Wearable: Advancing Human Health Through Portable SpectroscopyJuly 20, 2024 | msn.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up to $283.45Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up to $283.45July 19, 2024 | marketbeat.comBio-Rad: Economics Unsupportive With Capital Valued 70 Cents On The DollarJuly 14, 2024 | seekingalpha.comBio-Rad Laboratories (NYSE:BIO.B) Reaches New 12-Month Low at $268.24Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year Low at $268.24July 2, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Stock Price Passes Below 200 Day Moving Average of $311.79Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Below Two Hundred Day Moving Average of $311.79June 14, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Up 3%Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 3%June 4, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 17.3%Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 17.3%May 13, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55May 8, 2024 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Bio-Rad Laboratories (BIO), Caribou Biosciences (CRBU)May 8, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On Bio-Rad LaboratoriesMay 8, 2024 | markets.businessinsider.comBio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology researchMay 1, 2024 | msn.comBio-Rad Laboratories (NYSE:BIO.B) Sets New 12-Month Low at $268.80Bio-Rad Laboratories (NYSE:BIO.B) Sets New 1-Year Low at $268.80April 30, 2024 | marketbeat.comBio-Rad Laboratories (BIO.B) to Release Earnings on TuesdayBio-Rad Laboratories (NYSE:BIO.B) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports.April 30, 2024 | marketbeat.comOncology Market Expected to Grow at 9.6% CAGR, Reaching USD 533.2 Bn by 2032 | DMRApril 25, 2024 | finance.yahoo.comLyme Disease Diagnostic Market Research Report 2024: Global Trends, Forecasts and Competitive Analysis to 2030April 21, 2024 | finance.yahoo.comBio-Rad’s Chief Operating Officer Andrew Last to RetireApril 10, 2024 | businesswire.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address BIO.B Media Mentions By Week BIO.B Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO.B News Sentiment▼0.120.60▲Average Medical News Sentiment BIO.B News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO.B Articles This Week▼21▲BIO.B Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KEYS News Today FTV News Today VLTO News Today TER News Today RVTY News Today AVTR News Today NVMI News Today VNT News Today ST News Today CAMT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO.B) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO.B Stock Alerts